Coeptis Therapeutics Holdings, Inc.
Ticker: 1759186
P/L Snapshot
Q2 FY26 · consolidated
vs Q1 FY26·vs Q2 FY25
Revenue
1.58
+1336.4%+690.0%
Expenditure
15.38
+281.6%+225.8%
Net Profit
-13.79
-243.0%-218.5%
OPM %
-100.00%
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingCOEP
20263Nov
Board Meeting
Jeffery Harris, Chief Technology Officer, elected as a direc…
SEC Filing ↗ Board MeetingCOEP
202624Jun
Board Meeting
Appointment of Jeffery Harris as Chief Technology Officer. …
SEC Filing ↗ Board MeetingCOEP
202622May
Board Meeting
Michelle Burke resigned as Co-Chief Executive Officer and di…
SEC Filing ↗